On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

Instead of four equal quarterly distributions, AstraZeneca insists on two payments per year, with a greater portion announced ...

The FDA okays AstraZeneca's Fasenra for treating adults with eosinophilic granulomatosis with polyangiitis. This is the ...

Americans love their Star-Spangled Banner, the French are obsessed with national pride but we Brits have a patriotism problem ...

FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.

More than 39 million people around the world could die from antibiotic-resistant infections over the next 25 years, according to a study published in The Lancet.  The new study by the Global Research ...

Aronne, MD, of Weill Cornell Medicine in New York City, made a compelling case that the next generation of obesity ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

The threshold between one season and another, between one moment and the next, between one way of being and the next one: ...

These are still high on the list of AZ’s core focus today ... to have paid off – between 2005 and 2010 AstraZeneca‘s success rates for taking drugs from candidate nomination to phase ...

The Federal Trade Commission is accusing three companies of artificially inflating insulin list prices. We have new developments on a deadly Israeli strike in Lebanon. The Food & Drug Administration .